Copertina

Nanoparticles of cisplatin augment drug accumulations and inhibit multidrug resistance transporters in human glioblastoma cells

Background: Cisplatin (CSP) is a potent anticancer drug widely used in treating glioblastoma multiforme (GBM). However, CSP's clinical efficacy in GBM contrasted with low therapeutic ratio, toxicity, and multidrug resistance (MDR). Therefore, we have developed a system for the active targeting...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Naseer Maliyakkal (Autore), Asmy Appadath Beeran (Autore), Nayanabhirama Udupa (Autore)
Natura:	Libro
Pubblicazione:	Elsevier, 2021-08-01T00:00:00Z.
Soggetti:	article
Accesso online:	Connect to this object online.
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

In vitro anticancer activity of microbial isolates from diverse habitats
di: Angel Treasa Thomas, et al.
Pubblicazione: (2011)

Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation
di: Hyun-Jung Kim, et al.
Pubblicazione: (2015)

In vitro wound-healing effects of biosynthesized copper nanoparticles
di: Mradul Tiwari, et al.
Pubblicazione: (2016)

Synergism of cisplatin-oleanolic acid co-loaded hybrid nanoparticles on gastric carcinoma cells for enhanced apoptosis and reversed multidrug resistance
di: Danyang Li, et al.
Pubblicazione: (2020)

Ovarian hormones modulate multidrug resistance transporters in the ovary
di: Lynae M Brayboy, et al.
Pubblicazione: (2018)

Purification of a Multidrug Resistance Transporter for Crystallization Studies
di: Kamela O. Alegre, et al.
Pubblicazione: (2015)

Genetic knockdown and pharmacological inhibition of parasite multidrug resistance transporters disrupts egg production in Schistosoma mansoni.
di: Ravi S Kasinathan, et al.
Pubblicazione: (2011)

Enhanced Accumulation of Cisplatin in Ovarian Cancer Cells from Combination with Wedelolactone and Resulting Inhibition of Multiple Epigenetic Drivers
di: Sarwar S, et al.
Pubblicazione: (2021)

Augmented Therapeutic Potential of Glutaminase Inhibitor CB839 in Glioblastoma Stem Cells Using Gold Nanoparticle Delivery
di: Beatriz Giesen, et al.
Pubblicazione: (2021)

Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
di: Nan-Yao Lee, et al.
Pubblicazione: (2019)

Brain Delivery of Cisplatin Using Microbubbles in Combination with Ultrasound as an Effective Therapy for Glioblastoma
di: Fumiko Hagiwara, et al.
Pubblicazione: (2023)

Vesicle-Transported Multidrug Resistance as a Possible Therapeutic Target of Natural Compounds
di: Salvatrice Rigogliuso, et al.
Pubblicazione: (2024)

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
di: Ning Ji, et al.
Pubblicazione: (2018)

Synergistic effect of microRNA and albumin-bound nanoparticles for inhibition of glioblastoma cancer cell proliferation
di: Maria Shariatnasery, et al.
Pubblicazione: (2020)

Magnetic Graphene Oxide Nanocarrier for Targeted Delivery of Cisplatin: A Perspective for Glioblastoma Treatment
di: Sami A. Makharza, et al.
Pubblicazione: (2019)

Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1
di: Jiong Li, et al.
Pubblicazione: (2024)

Homotype-Targeted Biogenic Nanoparticles to Kill Multidrug-Resistant Cancer Cells
di: Imran Shair Mohammad, et al.
Pubblicazione: (2020)

Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein
di: Wenwen Xu, et al.
Pubblicazione: (2023)

Reversal of multidrug resistance in human lung cancer cells by delivery of 3-octadecylcarbamoylacrylic acid–cisplatin-based liposomes
di: Song J, et al.
Pubblicazione: (2017)

"Pincer movement": Reversing cisplatin resistance based on simultaneous glutathione depletion and glutathione S-transferases inhibition by redox-responsive degradable organosilica hybrid nanoparticles
di: Boyi Niu, et al.
Pubblicazione: (2022)

Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway
di: Wu S, et al.
Pubblicazione: (2016)

Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis
di: Qianwen Zhou, et al.
Pubblicazione: (2022)

Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer
di: Wujian Zheng, et al.
Pubblicazione: (2017)

Green synthesis of hyaluronic acid coated, thiolated chitosan nanoparticles for CD44 targeted delivery and sustained release of Cisplatin in cervical carcinoma
di: Kousain Kousar, et al.
Pubblicazione: (2023)

Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration
di: Siqi Wang, et al.
Pubblicazione: (2022)

A promising drug delivery candidate (CS-g-PMDA-CYS-fused gold nanoparticles) for inhibition of multidrug-resistant uropathogenic Serratia marcescens
di: Ping Shi, et al.
Pubblicazione: (2020)

Promising Antibacterial Effect of Copper Oxide Nanoparticles against Several Multidrug Resistant Uropathogens
di: Hadi Sedigh Ebrahim-Saraie, et al.
Pubblicazione: (2018)

MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: In vitro and in vivo study
di: Zhuo-Xun Wu, et al.
Pubblicazione: (2022)

Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cells
di: Xuan-Yu Chen, et al.
Pubblicazione: (2024)

Imperatorin Restores Chemosensitivity of Multidrug-Resistant Cancer Cells by Antagonizing ABCG2-Mediated Drug Transport
di: Chung-Pu Wu, et al.
Pubblicazione: (2023)

Sponge-derived alkaloid AP-7 as a sensitizer to cisplatin in the treatment of multidrug-resistant NSCLC via Chk1-dependent mechanisms
di: Li Guan, et al.
Pubblicazione: (2024)

Glioblastoma Multiforme Therapy and Mechanisms of Resistance
di: Yulian P. Ramirez, et al.
Pubblicazione: (2013)

ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells
di: Mingjin Wang, et al.
Pubblicazione: (2023)

MCF-7 and its Multidrug Resistant Variant MCF-7/ADR Overcome TNF Cytotoxicity through Prevention of Reactive Oxygen Species Accumulation
di: Morteza Ghandadi, et al.
Pubblicazione: (2019)

Lipid Polymeric Hybrid Nanoparticles: Formulation Techniques and Effects on Glioblastoma
di: Yudhishtir Singh Baghel, et al.
Pubblicazione: (2022)

Metformin Derivative HL156A Reverses Multidrug Resistance by Inhibiting HOXC6/ERK1/2 Signaling in Multidrug-Resistant Human Cancer Cells
di: Yun Soo Jeong, et al.
Pubblicazione: (2020)

Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment
di: Pedro M Costa, et al.
Pubblicazione: (2013)

Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin
di: Muhammad Muzamil Khan, et al.
Pubblicazione: (2019)

Multidrug-Resistant Bacterial Pathogens and Public Health: The Antimicrobial Effect of Cyanobacterial-Biosynthesized Silver Nanoparticles
di: Nermin A. El Semary, et al.
Pubblicazione: (2022)

GSH-responsive poly-resveratrol based nanoparticles for effective drug delivery and reversing multidrug resistance
di: Yang Liping, et al.
Pubblicazione: (2022)